Policy Research and Strategic Analysis
PDCI Market Access Inc has a senior team of experienced analysts and researchers that assess the economic, political, and health policy factors that affect pharmaceutical pricing, reimbursement, and market access systems in Canada and internationally. Research and analysis studies have covered a range of topics including:
- Price regulation policies
- Internal, external price referencing
- Innovation and price premiums
- Reimbursement policies
- Assessment of coverage, listing decisions
- Coverage policies
- Risk sharing agreements, Patient access schemes
- Generic drug policies
- Role of Health Technology Assessment (HTA)
- Cost-effectiveness thresholds
- Comparative effectiveness criteria
- Pricing and market access in emerging markets
- Low income, middle income, BRIC
- P&R, Market Access policies for
- Vaccines
- Blood, plasma derived products
- Parallel, Cross-Border Trade, Re-importation
- Role of Parallel trade in the EU
- Prospects for cross border trade (re-importation) in the US
- Comparative Analyses of International Pricing & Reimbursement Policies
- International price comparisons
- Reimbursement decision comparisons
- Trends and outlook
- Intellectual Property
- patent term extension,, data protection, orphan drugs policies, TRIPS
- patent term extension,, data protection, orphan drugs policies, TRIPS
